Cargando…

Virus-Induced Immunopathology

Several viruses cause damage to the tissue by immunopathological mechanisms. This chapter presents the principal examples of immunopathogenesis caused by the viruses, accompanied by speculations about its management. The most common mechanism of lesion development in virus induced immunopathology in...

Descripción completa

Detalles Bibliográficos
Autor principal: Rouse, Barry T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academic Press Inc. Published by Elsevier Inc. 1996
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7130923/
https://www.ncbi.nlm.nih.gov/pubmed/8895836
http://dx.doi.org/10.1016/S0065-3527(08)60739-3
_version_ 1783517121049788416
author Rouse, Barry T.
author_facet Rouse, Barry T.
author_sort Rouse, Barry T.
collection PubMed
description Several viruses cause damage to the tissue by immunopathological mechanisms. This chapter presents the principal examples of immunopathogenesis caused by the viruses, accompanied by speculations about its management. The most common mechanism of lesion development in virus induced immunopathology involves T cells. Usually, it seems that when CD8(+) T cells act as the controlling cell type, lesions are acute and the outcome is decided quickly. The classic example is provided by LCM in mice. The newest candidate may turn out to be SNV infection in humans. Lesions orchestrated primarily by CD4(+) T cells can be either acute or long-lasting. Curiously, in the LCMV example, if CD8(+) T cells are removed from the scene, immunopathological responses may still occur and these involve CD4(+) T cells. Such responses are far more chronic and of lower grade than those mediated by CD8(+) T lymphocytes. One possible sequel to chronic inflammatory responses to viruses is that autoreactive inflammatory reactions are initiated and an autoimmune disease occurs. The adage that an ounce of prevention is worth a pound of cure is certainly true in the field of viral pathogenesis. Preventing viral infection or manipulating immune processes during the initial phases of infection is far more successful than attempting to counteract pathological events once underway.
format Online
Article
Text
id pubmed-7130923
institution National Center for Biotechnology Information
language English
publishDate 1996
publisher Academic Press Inc. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-71309232020-04-08 Virus-Induced Immunopathology Rouse, Barry T. Adv Virus Res Article Several viruses cause damage to the tissue by immunopathological mechanisms. This chapter presents the principal examples of immunopathogenesis caused by the viruses, accompanied by speculations about its management. The most common mechanism of lesion development in virus induced immunopathology involves T cells. Usually, it seems that when CD8(+) T cells act as the controlling cell type, lesions are acute and the outcome is decided quickly. The classic example is provided by LCM in mice. The newest candidate may turn out to be SNV infection in humans. Lesions orchestrated primarily by CD4(+) T cells can be either acute or long-lasting. Curiously, in the LCMV example, if CD8(+) T cells are removed from the scene, immunopathological responses may still occur and these involve CD4(+) T cells. Such responses are far more chronic and of lower grade than those mediated by CD8(+) T lymphocytes. One possible sequel to chronic inflammatory responses to viruses is that autoreactive inflammatory reactions are initiated and an autoimmune disease occurs. The adage that an ounce of prevention is worth a pound of cure is certainly true in the field of viral pathogenesis. Preventing viral infection or manipulating immune processes during the initial phases of infection is far more successful than attempting to counteract pathological events once underway. Academic Press Inc. Published by Elsevier Inc. 1996 2008-04-10 /pmc/articles/PMC7130923/ /pubmed/8895836 http://dx.doi.org/10.1016/S0065-3527(08)60739-3 Text en © 1996 Academic Press Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Rouse, Barry T.
Virus-Induced Immunopathology
title Virus-Induced Immunopathology
title_full Virus-Induced Immunopathology
title_fullStr Virus-Induced Immunopathology
title_full_unstemmed Virus-Induced Immunopathology
title_short Virus-Induced Immunopathology
title_sort virus-induced immunopathology
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7130923/
https://www.ncbi.nlm.nih.gov/pubmed/8895836
http://dx.doi.org/10.1016/S0065-3527(08)60739-3
work_keys_str_mv AT rousebarryt virusinducedimmunopathology